Suchergebnisse - "Seror, Raphaele"

PubPharm (24)

1

Obinutuzumab in patients with Sjogren's disease immunised against rituximab

enthalten in: Annals of the rheumatic diseases | 2024

von Pezot, M. | Nocturne, G. | Belkhir, R. | +5

2

Rituximab as maintenance therapy for ANCA-associated vasculitides : pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials

enthalten in: Annals of the rheumatic diseases | 2024

von Delestre, F. | Charles, P. | Karras, A. | +104

3

Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent waves

enthalten in: Joint bone spine | 2023

von Drumez, E. | Richez, C. | Bebear, L. | +21

4

A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren's syndrome

enthalten in: JCI insight | 2022

von Mariette, X. | Barone, F. | Baldini, C. | +16

5

Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR) : a consensual composite score for assessing treatment effect in primary Sjögren's syndrome

enthalten in: Annals of the rheumatic diseases | 2022

von Seror, R. | Baron, G. | Camus, M. | +53

6

Rituximab Impairs B Cell Response But Not T Cell Response to COVID-19 Vaccine in Autoimmune Diseases

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2022

von Bitoun, S. | Henry, J. | Desjardins, D. | +12

CommentIn: Nat Rev Rheumatol. 2022 Mar;18(3):126. - PMID 35110747

7

Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses

enthalten in: RMD open | 2022

von Bitoun, S. | Avouac, J. | Henry, J. | +9

8

Epidemiology of cutaneous involvement in Sjögren syndrome : Data from three French pSS populations (TEARS, ASSESS, diapSS)

enthalten in: Joint bone spine | 2021

von Villon, C. | Orgeolet, L. | Roguedas, A. | +21

9

Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis

enthalten in: RMD open | 2021

von Bonnet, I. | Rousseau, A. | Duraffour, P. | +7

10

Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone

enthalten in: Annals of the rheumatic diseases | 2020

von Chevalier, K. | Belkhir, R. | Seror, R. | +2